Albuterol and Digoxin Interaction

Understanding the Albuterol and Digoxin Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Albuterol belongs to the Short-Acting Beta-2 Agonist class and Digoxin belongs to the Cardiac Glycoside class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Albuterol can lower the amount of digoxin in your blood, which might make the heart medicine less effective. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Albuterol has 16 total documented interactions on file in this dataset, and Digoxin has 120. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor should check your digoxin blood levels regularly to ensure the medicine is still working correctly. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Albuterol or Digoxin based on a web page, speak with your prescriber or pharmacist before making any change.